Skip to main content

Table 1 Cohort characteristics

From: The effect of preoperative topical magnesium sulfate spraying in the oropharyngeal region on postoperative sore throat following gynecological laparoscopic surgery: a randomized clinical trial

Variables

Control Group (n = 29)

Magnesium Group (n = 29)

p

Age (years)

41.47 ± 9.28

43.33 ± 9.65

0.448

Height (cm)

1.61 ± 0.05

1.61 ± 0.05

0.980

Weight (kg)

65.75 ± 8.7

62.03 ± 8.7

0.104

BMI (kg/m2)

25.26 ± 2.99

23.88 ± 3.26

0.093

Duration of tracheal intubation (min)

155.4 ± 47.9

137.9 ± 45.77

0.859

Preoperative serum albumin levels (g/dl)

47.023 ± 2.99

46.37 ± 3.37

0.433

Preoperative serum magnesium level (mmol/L)

0.81 ± 0.07

0.85 ± 0.07

0.116

Postoperative serum magnesium ion level (mmol/L)

0.8(0.77–0.82)

0.81(0.8–0.85)

0.286

The variation in serum magnesium ion levels before and after the surgical procedure (mmol/L)

−0.018 ± 0.03

−0.033 ± 0.047

0.128

Intraoperative fluid volume infusion (ml)

1000(1000–1250)

1000(1000–1250)

0.556

Intraoperative urine volume (ml)

100(75–105)

80(75–100)

0.078

Remifentanil (mg)

1.5(1.5–2)

1.63(1.19–2.25)

0.922

atropine (mg)

0(0–0)

0(0–0)

0.321

Cuff pressure (mmHg)

   

5 min after intubation

24(24–24)

24(22–24)

0.088

30 min after intubation

24(24–24)

24(22–24)

0.318

1 h after intubation

24(24–24)

24(22–24)

0.505

90 min after intubation

24(24–24)

24(24–24)

0.985

  1. BMI = body mass index. Values are shown as percentages, mean ± standard deviation, or median (interquartile range)